Summary Stage 2018: Lacrimal Gland/Sac
Summary Stage 2018
Notes
**Lacrimal Gland/Sac**
8000-8700, 8941, 8980, 8982, 9700-9701
C695
C695 Lacrimal gland
C695 Lacrimal sac
**Note 1:** The following sources were used in the development of this chapter
* SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998) (https://seer.cancer.gov/archive/manuals/EOD10Dig.3rd.pdf)
* SEER Summary Staging Manual-2000: Codes and Coding Instructions (https://seer.cancer.gov/tools/ssm/ssm2000/)
* Collaborative Stage Data Collection System, version 02.05: https://cancerstaging.org/cstage/Pages/default.aspx
* Chapter 69 *Lacrimal Gland Carcinoma*, in the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Used with permission of the American College of Surgeons, Chicago, Illinois.
**Note 2:** See the following chapters for the listed histologies
* 8710-8714, 8800-8921, 8932-8934, 8940, 8950-8975, 8981, 8983-8990, 9000-9016, 9030-9137, 9141-9175, 9181-9230, 9240-9509, 9520-9582: *Orbital Sarcoma*
* 8720-8790: *Eye Other*
* 8930-8931, 8991, 9020, 9180, 9231: *Soft Tissue*
* 8935-8936: *GIST*
* 9140: *Kaposi Sarcoma*
* 9510-9514: *Retinoblastoma*
**Note 3:** Summary Stage is the only applicable staging system for Lacrimal Sac.
| SS2018 |
Description |
| 0 |
In situ: noninvasive, intraepithelial |
| 1 |
Localized only (localized, NOS)
- Confined to lacrimal gland
+ WITH or WITHOUT extraglandular extension into the orbital soft tissue
+ No periosteal or orbital bone involvement or UNKNOWN if involved |
| 2 |
Regional by direct extension only
- Confined to lacrimal gland
+ AND involvement of periosteum AND/OR periorbital bone |
| 3 |
Regional lymph node(s) involved only
- Cervical, NOS
- Mandibular, NOS
+ Submandibular (submaxillary)
- Parotid, NOS
+ Infra-auricular
+ Preauricular
- Regional lymph node(s), NOS
+ Lymph node(s), NOS |
| 4 |
Regional by BOTH direct extension AND regional lymph node(s) involved
- Codes (2) + (3) |
| 7 |
Distant site(s)/lymph node(s) involved
- Distant site(s) (including further contiguous extension)
+ Adjacent structure(s), NOS
+ Brain
+ Cavernous sinus
+ Orbital bone
+ Periosteum
+ Pterygoid fossa
+ Sinuses
+ Superior orbital fissure
+ Temporal fossa
- Distant lymph node(s), NOS
- Distant metastasis, NOS
+ Carcinomatosis
+ Distant metastasis WITH or WITHOUT distant lymph node(s) |
| 9 |
Unknown if extension or metastasis |
(1) Fritz AG, Ries LAG (eds). **SEER Extent of Disease 1988: Codes and Coding Instructions (3rd Edition, 1998)**, National Cancer Institute, NIH Pub. No. 98-2313, Bethesda, MD, 1998
(2) Young JL Jr, Roffers SD, Ries LAG, Fritz AG, Hurlbut AA (eds.). **SEER Summary Staging Manual-2000: Codes and Coding Instructions**, National Cancer Institute, NIH Pub. No. 01-4969, Bethesda, MD, 2001.
(3) Collaborative Stage Work Group of the American Joint Committee on Cancer. **Collaborative Stage Data Collection System User Documentation and Coding Instructions, version 02.05**. American Joint Committee on Cancer (Chicago, IL)
(4) Gress, D.M., Edge, S.B., Gershenwald, J.E., et al. **Principles of Cancer Staging**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 3-30
(5) White, V.A., Finger, P.T., et al. **Lacrimal Gland Carcinoma**. In: Amin, M.B., Edge, S.B., Greene, F.L., et al. (Eds.) AJCC Cancer Staging Manual. 8th Ed. New York: Springer; 2017: 833-839
